Es gab 50 kürzliche Insider-Transaktionen für Better Therapeutics, Inc. (BTTX), darunter 47 Käufe und 2 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $7.4M und die gesamten Insider-Verkäufe auf $11K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Perry David P, Lavizzo-mourey Risa J, Karbe Frank. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — BTTX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-02-09 |
Perry David P |
10 Percent Owner, Officer: Executive Chairman |
RSU-Zuteilung |
839,895 |
$0.19 |
$160K |
2,416,634 |
| 2024-01-09 |
Perry David P |
10 Percent Owner, Officer: Executive Chairman |
RSU-Zuteilung |
1,471,453 |
$0.17 |
$250K |
1,576,739 |
| 2023-12-18 |
Lavizzo-mourey Risa J |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
13,750 |
| 2023-12-18 |
Perry David P |
10 Percent Owner, Officer: Executive Chairman |
RSU-Zuteilung |
3,750 |
- |
- |
105,286 |
| 2023-12-18 |
Karbe Frank |
Chief Executive Officer |
RSU-Zuteilung |
62,500 |
- |
- |
526,516 |
| 2023-12-18 |
Carmona Richard H |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
157,369 |
| 2023-12-18 |
Parker Geoffrey M. |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
1,031,805 |
| 2023-12-18 |
Granger Elder |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
39,601 |
| 2023-12-18 |
Armanino Andrew J. |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
17,084 |
| 2023-12-18 |
Wynholds Kristin |
Chief Product Officer |
RSU-Zuteilung |
25,362 |
- |
- |
225,631 |
| 2023-12-18 |
Berman Mark A. |
Chief Medical Officer |
RSU-Zuteilung |
25,362 |
- |
- |
448,140 |
| 2023-12-18 |
Miller Leslie A. |
Principal Accounting Officer |
RSU-Zuteilung |
3,587 |
- |
- |
17,937 |
| 2023-11-27 |
Miller Leslie A. |
Principal Accounting Officer |
Veräußerung |
9,650 |
$1.14 |
$11K |
- |
| 2023-07-27 |
Perry David P |
10 Percent Owner, Officer: Executive Chairman |
Informierter Kauf |
1,233,045 |
$0.73 |
$900K |
13,030,393 |
| 2023-07-27 |
Karbe Frank |
Chief Executive Officer |
Informierter Kauf |
137,005 |
$0.73 |
$100K |
429,429 |
| 2023-07-27 |
Parker Geoffrey M. |
Director |
Informierter Kauf |
685,025 |
$0.73 |
$500K |
1,028,055 |
| 2023-07-27 |
Granger Elder |
Director |
Informierter Kauf |
34,251 |
$0.73 |
$25K |
35,851 |
| 2023-07-27 |
Armanino Andrew J. |
Director |
Informierter Kauf |
274,010 |
$0.73 |
$200K |
728,368 |
| 2023-07-27 |
Berman Mark A. |
Chief Medical Officer |
Informierter Kauf |
54,802 |
$0.73 |
$40K |
388,191 |
| 2023-06-07 |
Lavizzo-mourey Risa J |
Director |
RSU-Zuteilung |
15,000 |
$0.77 |
$11.55K |
15,000 |
| 2023-06-07 |
Perry David P |
10 Percent Owner, Officer: Executive Chairman |
RSU-Zuteilung |
15,000 |
$0.77 |
$11.55K |
15,000 |
| 2023-06-07 |
Carmona Richard H |
Director |
RSU-Zuteilung |
15,000 |
$0.77 |
$11.55K |
15,000 |
| 2023-06-07 |
Parker Geoffrey M. |
Director |
RSU-Zuteilung |
15,000 |
$0.77 |
$11.55K |
15,000 |
| 2023-06-07 |
Granger Elder |
Director |
RSU-Zuteilung |
15,000 |
$0.77 |
$11.55K |
15,000 |
| 2023-06-07 |
Armanino Andrew J. |
Director |
RSU-Zuteilung |
15,000 |
$0.77 |
$11.55K |
15,000 |
| 2023-05-16 |
Granger Elder |
Director |
Informierter Kauf |
600 |
$0.87 |
$520.32 |
1,600 |
| 2023-04-10 |
Perry David P |
10 Percent Owner, Officer: See Remarks |
Informierter Kauf |
3,636,364 |
$0.83 |
$3M |
3,636,364 |
| 2023-04-10 |
Karbe Frank |
See Remarks |
Informierter Kauf |
242,424 |
$0.83 |
$200K |
292,424 |
| 2023-04-10 |
Parker Geoffrey M. |
Director |
Informierter Kauf |
303,030 |
$0.83 |
$250K |
343,030 |
| 2023-04-10 |
Armanino Andrew J. |
Director |
Informierter Kauf |
303,030 |
$0.83 |
$250K |
454,358 |
| 2023-04-10 |
Georgianna Maule-ffinch 2015 Trust |
10 Percent Owner |
Veräußerung |
- |
- |
- |
3,636,364 |
| 2023-04-05 |
Heinen Mark |
Chief Financial Officer |
RSU-Zuteilung |
54,000 |
- |
- |
139,723 |
| 2023-04-05 |
Wynholds Kristin |
Chief Product Officer |
RSU-Zuteilung |
101,450 |
- |
- |
200,269 |
| 2023-04-05 |
Berman Mark A. |
Chief Medical Officer |
RSU-Zuteilung |
101,450 |
- |
- |
333,389 |
| 2023-03-01 |
Heinen Mark |
Chief Financial Officer |
RSU-Zuteilung |
28,550 |
$1.14 |
$32.55K |
28,550 |
| 2023-03-01 |
Wynholds Kristin |
Chief Product Officer |
RSU-Zuteilung |
101,450 |
$1.14 |
$115.65K |
101,450 |
| 2023-03-01 |
Berman Mark A. |
Chief Medical Officer |
RSU-Zuteilung |
101,450 |
$1.14 |
$115.65K |
101,450 |
| 2022-11-30 |
Heinen Mark |
See Remarks |
RSU-Zuteilung |
15,723 |
$1.24 |
$19.51K |
85,723 |
| 2022-11-30 |
Wynholds Kristin |
Chief Product Officer |
RSU-Zuteilung |
3,781 |
$1.24 |
$4.69K |
98,819 |
| 2022-09-16 |
Perry David P |
10 Percent Owner, Officer: See Remarks |
Informierter Kauf |
39,156 |
$2.07 |
$80.97K |
101,536 |
| 2022-09-15 |
Karbe Frank |
See Remarks |
Informierter Kauf |
50,000 |
$2.09 |
$104.7K |
50,000 |
| 2022-09-15 |
Perry David P |
10 Percent Owner, Officer: See Remarks |
Informierter Kauf |
10,844 |
$1.99 |
$21.62K |
62,380 |
| 2022-09-13 |
Heinen Mark |
See Remarks |
Informierter Kauf |
26,132 |
$1.94 |
$50.7K |
70,000 |
| 2022-09-12 |
Heinen Mark |
See Remarks |
Informierter Kauf |
23,868 |
$1.94 |
$46.3K |
43,868 |
| 2022-07-05 |
Karbe Frank |
See Remarks |
Unbekannt |
- |
- |
- |
- |
| 2022-07-05 |
Karbe Frank |
See Remarks |
RSU-Zuteilung |
472,200 |
$1.68 |
$793.3K |
472,200 |
| 2022-06-24 |
Heinen Mark |
See Remarks |
Informierter Kauf |
2,281 |
$1.75 |
$4K |
2,281 |
| 2022-06-14 |
Armanino Andrew J. |
Director |
Informierter Kauf |
15,000 |
$1.39 |
$20.85K |
15,000 |
| 2022-06-13 |
Parker Geoffrey M. |
Director |
Informierter Kauf |
25,000 |
$1.45 |
$36.18K |
40,000 |
| 2022-06-10 |
Heinen Mark |
See Remarks |
Informierter Kauf |
5,000 |
$1.56 |
$7.8K |
20,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall